Search
Now showing items 1-10 of 10
Article
New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: higher potency and lower hepatocytotoxicity
| Date Issued:
2018 | Copyright:
restricted access
Article
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study
| Date Issued:
2015 | Copyright:
open access
Article
Experimental and theoretical NMR determination of isoniazid and sodium p-sulfonatocalix[n]arenes inclusion complexes
| Date Issued:
2012 | Copyright:
open access
Article
Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults
| Date Issued:
2018 | Copyright:
open access
Preprint
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model
| Date Issued:
2014 | Copyright:
open access
Article
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
| Date Issued:
2007 | Copyright:
open access
Article
Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro
| Date Issued:
2009 | Copyright:
open access
Article
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
| Date Issued:
2014 | Copyright:
open access
Article
Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives
| Date Issued:
2010 | Copyright:
open access
Article
One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis
| Date Issued:
2019 | Copyright:
restricted access